Sarepta Therapeutics (0L35.LSE) Q3 2024 Earnings

Aug 7Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.22
-0.54
0.14
0.82

Details

Expected EPS
-0.129478
Actual EPS
0.07
Surprise EPS
0.2
Surprise Percent
+154.06%

Description

⁨Sarepta Therapeutics⁩ (⁦0L35.LSE⁩) has reported earnings of ⁦0.07⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts